Central Serous Chorioretinopathy (CSCR)
Κεντρική Ορώδης Χοριοαμφιβληστροειδοπάθεια (ΚΟΧΑ – Central Serous Chorioretinopathy)
Central Serous Chorioretinopathy (CSCR) is a condition affecting the macula (the central part of the retina responsible for sharp vision). The disease occurs more frequently in men than in women, particularly between the ages of 22 and 50. The exact cause of the condition is not fully clarified. It is believed that intense stress is one of the primary causes of the problem. It is caused by ruptures in the connections between the cells of the retinal pigment epithelium (the pigment layer of the retina). Fluid from the blood vessels of the choroid layer, located beneath the retina, passes through these ruptures, creating a small retinal detachment beneath the macula. In most cases, it is considered a benign condition and often resolves on its own (the accumulated serous fluid dissipates without treatment).
What are the symptoms?
Central Serous Chorioretinopathy (or chorioretinal disease) typically causes a blurring of central vision (or a central blind spot in the visual field). The patient may also complain of distorted vision (metamorphopsia) or even a ‘faded’ color perception.
How is it diagnosed?
A thorough ophthalmologic examination is essential. The examination includes fundoscopy (after pupil dilation), where fluid accumulation beneath the macula is observed. Optical Coherence Tomography (OCT) and angiography provide detailed mapping of the ‘suspect’ area, offering valuable insights for monitoring and understanding the progression of the disease.
An essential element of any surgical procedure, especially cosmetic surgery, is providing the patient with sufficient time for information.
What is the Treatment?
In most cases (about 94% of patients), Central Serous Chorioretinopathy does not require treatment, as it is self-limiting (it resolves on its own). Therapeutic intervention is only considered when the condition does not resolve within approximately three months. A highly safe therapeutic approach is the use of ‘cold’ laser photodynamic therapy (PDT).
‘Thermal’ laser (low intensity) with the technique of photocoagulation therapy is applied when fluorescein angiography findings show that the fluid leakage sites are located away from the central macular area, meaning they can be ‘sealed’. In some cases, acetazolamide is recommended to accelerate the absorption of subretinal fluid.
Why choose Dr. Trakos?
Dr. Trakos’ contribution to the field of anterior segment and cataract surgery, as well as to the treatment of vision problems, has changed the lives of many people by improving their sight and quality of life
ΠΡΙΝ
ΜΕΤΑ
Τελευταία Άρθρα
Address
Address
Copyright © 2023, EyeLid